Michael Garrison, PhD

Dr. Garrison is the worldwide leader of R&D for the Becton Dickinson (BD) Medication and Procedural Solutions Business Unit. He led all aspects of BDX R&D integration associated with the acquisition of CareFusion, and merged R&D functions of BD Medical Surgical Systems and CareFusion Procedural Solutions Business Units. Dr. Garrison is accountable for all aspects of Strategic Innovation, Technology Development, Portfolio Execution and Delivery, and Product Engineering, and is responsible for talent development and management of a global team of over 400 people and an annual budget of over $100 million. Previously he served as BD Senior Business Director in global Hypodermic and Anesthesia businesses, where he was accountable for all aspects of global strategy development, responsible for ensuring global regulatory compliance, and globally launched multiple new products across all businesses. When he first joined BD in 2005 as Director of Advanced Technology, Dr. Garrison led a change management effort that resulted in implementation of improved global product, technology, and concept development processes for the company. Prior to BD, Dr. Garrison served as Manager of R&D for the surgical heart valve franchise at Edwards Lifesciences, Global Marketing Manager at Roche Diagnostics, and as a Research Scientist at Cygnus Therapeutic Systems. In these roles he was responsible for developing and commercializing new medical technologies in global markets. Dr. Garrison received BS and MS degrees in biomedical engineering from Duke University, and a PhD in bioengineering from the University of Washington, where he was advised by Dr. Buddy Ratner. Dr. Garrison is a member of the BD Extended Leadership Team, Business Unit Leadership Team, Innovation Council, and Operating Team, BDX R&D Management Council, Office of Science, Medicine, and Technology, and Greater Asia Innovation Council. He also serves as a member of the BDRx Board of Directors, and is an observer on the Great Lakes Pharmaceuticals Board of Directors. He is currently an Affiliate Associate Professor in the University of Washington Department of Bioengineering.

  • Vice President of Research & Development, Becton Dickinson
  • Affiliate Associate Professor, Department of Bioengineering, University of Washington